§ 4652. Monitoring for anticompetitive behavior
The Agency of Human Services shall consult with the Office of the Attorney General to identify the potential, and to monitor, for anticompetitive behavior in industries that would be affected by a wholesale prescription drug importation program. (Added 2017, No. 133 (Adj. Sess.), § 1, eff. May 21, 2018.)
Structure Vermont Statutes
Chapter 91 - Prescription Drug Cost Containment
§ 4605. Alternative drug or biological product selection
§ 4622. Evidence-based education program
§ 4631. Confidentiality of prescription information
§ 4631a. Expenditures by manufacturers of prescribed products
§ 4632. Disclosure of allowable expenditures and gifts by manufacturers of prescribed products
§ 4633. Pharmaceutical marketer price disclosure
§ 4634. Prescription drug price disclosure
§ 4635. Prescription drug cost transparency
§ 4636. Impact of prescription drug costs on health insurance premiums; report
§ 4637. Notice of introduction of new high-cost prescription drugs
§ 4651. Wholesale importation program for prescription drugs; design
§ 4652. Monitoring for anticompetitive behavior